Sec Form 4 Filing - Burton Daniel D. @ Health Catalyst, Inc. - 2020-06-25

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Burton Daniel D. 2. Issuer Name and Ticker or Trading Symbol Health Catalyst, Inc. [ HCAT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) C/O HEALTH CATALYST, INC., 3165 MILLROCK DRIVE, #400 3. Date of Earliest Transaction (MM/DD/YY) 06/25/2020 (Street) SALT LAKE CITY, UT84121 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 06/25/2020 M 104,662 A $ 4.42 262,162 D Common Stock 06/25/2020 M 8,924 A $ 6.24 271,086 D Common Stock 06/25/2020 S( 1 ) 8,924 D ( 2 ) $ 31.53 262,162 D Common Stock 06/25/2020 S( 1 ) 104,662 D ( 3 ) $ 30.98 157,500 D Common Stock 06/25/2020 M 2,883 A $ 4.42 160,383 D Common Stock 06/25/2020 S( 1 ) 2,883 D ( 2 ) $ 31.53 157,500 D Common Stock 06/26/2020 M 24,439 A $ 6.24 181,939 D Common Stock 06/26/2020 S( 1 ) 24,439 D ( 4 ) $ 30.25 157,500 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 6.24 06/25/2020 M 8,924 05/13/2018( 5 ) 06/12/2024 Common Stock 8,924 $ 0 67,541 D Stock Option (Right to Buy) $ 4.42 06/25/2020 M 107,545 07/01/2017( 6 ) 07/01/2023 Common Stock 107,545 $ 0 0 D Stock Option (Right to Buy) $ 6.24 06/26/2020 M 24,439 05/13/2018( 5 ) 06/12/2024 Common Stock 24,439 $ 0 43,102 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Burton Daniel D. C/O HEALTH CATALYST, INC. 3165 MILLROCK DRIVE, #400 SALT LAKE CITY, UT84121 X Chief Executive Officer Signatures /s/ Daniel Orenstein, as Attorney-in-Fact 06/29/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on November 22, 2019, in accordance with Rule 10b5-1. ( 2 )Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $31.42 to $31.72, inclusive. ( 3 )Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.42 to $31.41, inclusive. ( 4 )Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $30.00 to $30.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4). ( 5 )25% of the 76,465 shares underlying the options vested in an annual installment on May 13, 2015 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on May 13, 2018. ( 6 )25% of the 200,000 shares underlying the options vested in an annual installment on July 1, 2014 and the remaining balance vested or will vest in equal monthly installments until the option is vested in full on July 1, 2017.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.